{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:43:11Z","timestamp":1790314991232,"version":"4.1.0"},"reference-count":69,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X030067\/1"],"award-info":[{"award-number":["MR\/X030067\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,7,30]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Neonatal death and later disability remain common sequelae of hypoxic-ischaemic encephalopathy (HIE) despite the now standard use of therapeutic hypothermia (HT). New therapeutic approaches to brain protection are required. Melatonin is an indolamine hormone with free-radical scavenging, antiapoptotic, anti-inflammatory and gene regulatory neuroprotective properties, which has extensive preclinical evidence of safety and efficacy. Pharmacokinetic (PK) data suggest it is necessary to reach melatonin levels of 15\u201330\u2009mg\/L within 6\u20138\u2009hours of hypoxia-ischaemia for brain protection. We developed a novel Good Manufacturing Practice (GMP) grade melatonin in ethanol 50 mg\/mL solution for intravenous use. In preclinical studies, ethanol is an adjuvant excipient with additional neuroprotective benefit; optimised dosing protocols can achieve therapeutic melatonin levels while limiting blood alcohol concentrations (BACs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The Acute High Dose Melatonin for Encephalopathy of the Newborn (ACUMEN) Study is a first-in-human, international, multicentre, phase 1 safety study of intravenous melatonin in babies with moderate\/severe HIE receiving HT. Sixty babies will be studied over two phases: a dose escalation study including four dose levels to establish the recommended phase 2 dose (RP2D), followed by a 6-month cohort expansion study of RP2D to further characterise PKs and affirm safety. Participants will receive a 2-hour intravenous infusion of melatonin within 6\u2009hours of birth, followed by five maintenance doses every 12\u2009hours to cover the period of HT. Plasma melatonin and BACs will be monitored. The RP2D will be based on the attainment of therapeutic melatonin levels while limiting BACs and the frequency of dose-limiting events (DLEs). A Bayesian Escalation with Overdose Control approach will be used to estimate the risk of DLE per dose level, with a target level of &lt;33%. ACUMEN will establish a network of centres with standardised neurocritical care and harmonised MRI systems for the analysis of the primary outcome\u2014magnetic resonance spectroscopy (MRS) lactate to N-acetylaspartate peak area ratio localised to the basal ganglia and thalamus and include a nested blood biomarker study to explore early disease severity indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Approval has been given by the London Central National Health Service Health Research Authority Ethics Committee (25\/LO\/0170) and UK Clinical Trials Authorisation from the Medicines and Healthcare products Regulatory Agency. Separate approvals have been sought in Ireland and Australia. Dissemination will be via peer-reviewed journals, conference presentations, public registries and plain language summaries for parent\/legal guardian(s), in accordance with national requirements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN61218504\">ISRCTN61218504<\/jats:ext-link>\n                      . EU CT: 2025-520538-49-00.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Protocol version<\/jats:title>\n                    <jats:p>Publication based on the UK protocol V.3.0, 08 May 2025<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-107083","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T10:50:43Z","timestamp":1755859843000},"page":"e107083","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Acute High Dose Melatonin for Encephalopathy of the Newborn (ACUMEN) Study: a protocol for a multicentre phase 1 safety trial of melatonin to augment therapeutic hypothermia for moderate\/severe hypoxic ischaemic encephalopathy"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"isrctn61218504","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2004-6650","authenticated-orcid":false,"given":"Raymand","family":"Pang","sequence":"first","affiliation":[{"name":"EGA Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Macneil","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Trials Unit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvi","family":"Wadke","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Trials Unit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Jaami","sequence":"additional","affiliation":[{"name":"Joint Research Office, University College London Hospitals\/University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Marlow","sequence":"additional","affiliation":[{"name":"EGA Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F","family":"Standing","sequence":"additional","affiliation":[{"name":"Great Ormond Street Institute of Child Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim-Moulay","family":"Dehbi","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Trials Unit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Tranter","sequence":"additional","affiliation":[{"name":"Translational Research Office, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5783-0828","authenticated-orcid":false,"given":"Nicola J","family":"Robertson","sequence":"additional","affiliation":[{"name":"EGA Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2025123106471524000_15.8.e107083.1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313707"},{"key":"2025123106471524000_15.8.e107083.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119660"},{"key":"2025123106471524000_15.8.e107083.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7218"},{"key":"2025123106471524000_15.8.e107083.4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apa.14821","article-title":"Systematic review: long-term cognitive and behavioural outcomes of neonatal hypoxic-ischaemic encephalopathy in children without cerebral palsy","volume":"109","author":"Schreglmann","year":"2020","journal-title":"Acta Paediatr"},{"key":"2025123106471524000_15.8.e107083.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2021.101274","article-title":"Neurological and developmental outcomes following neonatal encephalopathy treated with therapeutic hypothermia","volume":"26","author":"Marlow","year":"2021","journal-title":"Semin Fetal Neonatal Med"},{"key":"2025123106471524000_15.8.e107083.6","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-316509"},{"key":"2025123106471524000_15.8.e107083.7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","article-title":"Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial","volume":"15","author":"Azzopardi","year":"2016","journal-title":"Lancet Neurol"},{"key":"2025123106471524000_15.8.e107083.8","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa211","article-title":"Melatonin and\/or erythropoietin combined with hypothermia in a piglet model of perinatal asphyxia","volume":"3","author":"Pang","year":"2021","journal-title":"Brain Commun"},{"key":"2025123106471524000_15.8.e107083.9","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab172","article-title":"Recombinant erythropoietin does not augment hypothermic white matter protection after global cerebral ischaemia in near-term fetal sheep","volume":"3","author":"Wassink","year":"2021","journal-title":"Brain Commun"},{"key":"2025123106471524000_15.8.e107083.10","doi-asserted-by":"publisher","DOI":"10.1113\/JP279131"},{"key":"2025123106471524000_15.8.e107083.11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115481","article-title":"Melatonin for Neonatal Encephalopathy: From Bench to Bedside","volume":"22","author":"Pang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025123106471524000_15.8.e107083.12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60858-x","article-title":"High-Dose Melatonin and Ethanol Excipient Combined with Therapeutic Hypothermia in a Newborn Piglet Asphyxia Model","volume":"10","author":"Robertson","year":"2020","journal-title":"Sci Rep"},{"key":"2025123106471524000_15.8.e107083.13","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2013.174"},{"key":"2025123106471524000_15.8.e107083.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00139-6"},{"key":"2025123106471524000_15.8.e107083.15","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.629576"},{"key":"2025123106471524000_15.8.e107083.16","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12169"},{"key":"2025123106471524000_15.8.e107083.17","first-page":"366","article-title":"Reduced Apoptosis by Ethanol and Its Association with PKC-\u03b4 and Akt Signaling in Ischemic Stroke","volume":"5","author":"Hafeez","year":"2014","journal-title":"Aging Dis"},{"key":"2025123106471524000_15.8.e107083.18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/acn3.51559","article-title":"Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia","volume":"9","author":"Pang","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2025123106471524000_15.8.e107083.19","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034947"},{"key":"2025123106471524000_15.8.e107083.20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/brain\/aws285","article-title":"Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model","volume":"136","author":"Robertson","year":"2013","journal-title":"Brain (Bacau)"},{"key":"2025123106471524000_15.8.e107083.21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nbd.2018.10.004","article-title":"Melatonin as an adjunct to therapeutic hypothermia in a piglet model of neonatal encephalopathy: A translational study","volume":"121","author":"Robertson","year":"2019","journal-title":"Neurobiol Dis"},{"key":"2025123106471524000_15.8.e107083.22","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12962","article-title":"Melatonin reduces brain injury following inflammation-amplified hypoxia-ischemia in a translational newborn piglet study of neonatal encephalopathy","volume":"76","author":"Pang","year":"2024","journal-title":"J Pineal Res"},{"key":"2025123106471524000_15.8.e107083.23","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12479","article-title":"Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs","volume":"64","author":"Aridas","year":"2018","journal-title":"J Pineal Res"},{"key":"2025123106471524000_15.8.e107083.24","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12744","article-title":"Melatonin augments the neuroprotective effects of hypothermia in lambs following perinatal asphyxia","volume":"71","author":"Aridas","year":"2021","journal-title":"J Pineal Res"},{"key":"2025123106471524000_15.8.e107083.25","doi-asserted-by":"crossref","unstructured":"Kim J , Sandoval K , Poddar A , et al . The neonatal gyrencephalic cortex maintains regionally distinct streams of neuroblasts. Neuroscience 2023. doi:10.1101\/2023.06.06.543768","DOI":"10.1101\/2023.06.06.543768"},{"key":"2025123106471524000_15.8.e107083.26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2938"},{"key":"2025123106471524000_15.8.e107083.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165744","article-title":"Amplitude Integrated Electroencephalogram as a Prognostic Tool in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review","volume":"11","author":"Del R\u00edo","year":"2016","journal-title":"PLoS One"},{"key":"2025123106471524000_15.8.e107083.28","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-315478"},{"key":"2025123106471524000_15.8.e107083.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30325-9"},{"key":"2025123106471524000_15.8.e107083.30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/PCC.0000000000002346","article-title":"Hypothermia Plus Melatonin in Asphyctic Newborns: A Randomized-Controlled Pilot Study","volume":"21","author":"Jerez-Calero","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"2025123106471524000_15.8.e107083.31","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-079X.2001.310409.x"},{"key":"2025123106471524000_15.8.e107083.32","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41390-024-03742-y","article-title":"Pro-inflammatory biomarkers and long term neurological outcomes in hypothermia plus melatonin treated asphyxiated newborns. A preliminary approach","volume":"97","author":"Jerez Calero","year":"2025","journal-title":"Pediatr Res"},{"key":"2025123106471524000_15.8.e107083.33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.73.3.405","article-title":"American Academy of Pediatrics Commitee on Drugs Ethanol in liquid preparations intended for children","volume":"73","year":"1984","journal-title":"Pediatrics"},{"key":"2025123106471524000_15.8.e107083.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2008.03.008"},{"key":"2025123106471524000_15.8.e107083.35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/15563650.2012.672743","article-title":"The acute effects of ethanol and acetaldehyde on physiological responses after ethanol ingestion in young healthy men with different ALDH2 genotypes","volume":"50","author":"Bae","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"2025123106471524000_15.8.e107083.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.10.005"},{"key":"2025123106471524000_15.8.e107083.37","first-page":"463","article-title":"Involvement of acetaldehyde for full protection against alcoholism by homozygosity of the variant allele of mitochondrial aldehyde dehydrogenase gene in Asians","volume":"9","author":"Peng","year":"1999","journal-title":"Pharmacogenetics"},{"key":"2025123106471524000_15.8.e107083.38","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000096"},{"key":"2025123106471524000_15.8.e107083.39","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-317399"},{"key":"2025123106471524000_15.8.e107083.40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106605","article-title":"Controlled backfill in oncology dose-finding trials","volume":"111","author":"Dehbi","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"2025123106471524000_15.8.e107083.41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.22131","article-title":"Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial","volume":"6","author":"Juul","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025123106471524000_15.8.e107083.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.10.067"},{"key":"2025123106471524000_15.8.e107083.43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41390-021-01438-1","article-title":"Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes","volume":"92","author":"Pang","year":"2022","journal-title":"Pediatr Res"},{"key":"2025123106471524000_15.8.e107083.44","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.734540","article-title":"Altered Cytokine Endotoxin Responses in Neonatal Encephalopathy Predict MRI Outcomes","volume":"9","author":"O\u2019Dea","year":"2021","journal-title":"Front Pediatr"},{"key":"2025123106471524000_15.8.e107083.45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaneurol.2018.4182","article-title":"Validation of Altered Umbilical Cord Blood MicroRNA Expression in Neonatal Hypoxic-Ischemic Encephalopathy","volume":"76","author":"O\u2019Sullivan","year":"2019","journal-title":"JAMA Neurol"},{"key":"2025123106471524000_15.8.e107083.46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000533473","article-title":"Neuro-Specific and Immuno-Inflammatory Biomarkers in Umbilical Cord Blood in Neonatal Hypoxic-Ischemic Encephalopathy","volume":"121","author":"Toorell","year":"2024","journal-title":"Neonatology"},{"key":"2025123106471524000_15.8.e107083.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.06.078"},{"key":"2025123106471524000_15.8.e107083.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050520","article-title":"The metabolomic profile of umbilical cord blood in neonatal hypoxic ischaemic encephalopathy","volume":"7","author":"Walsh","year":"2012","journal-title":"PLoS One"},{"key":"2025123106471524000_15.8.e107083.49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41390-021-01741-x","article-title":"Neonatal encephalopathy plasma metabolites are associated with neurodevelopmental outcomes","volume":"92","author":"Friedes","year":"2022","journal-title":"Pediatr Res"},{"key":"2025123106471524000_15.8.e107083.50","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/acem.14366","article-title":"Accuracy of a rapid glial fibrillary acidic protein\/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury","volume":"28","author":"Bazarian","year":"2021","journal-title":"Acad Emerg Med"},{"key":"2025123106471524000_15.8.e107083.51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42834-x","article-title":"NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing","volume":"14","author":"Feng","year":"2023","journal-title":"Nat Commun"},{"key":"2025123106471524000_15.8.e107083.52","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305206"},{"key":"2025123106471524000_15.8.e107083.53","doi-asserted-by":"crossref","unstructured":"Chalak LF , Pappas A , Tan S , et al . Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up: A Nested Multisite Cohort Study. JAMA Neurol 2021. doi:10.1001\/jamaneurol.2021.3723","DOI":"10.1001\/jamaneurol.2021.3723"},{"key":"2025123106471524000_15.8.e107083.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2008.07.018"},{"key":"2025123106471524000_15.8.e107083.55","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00393","article-title":"Cerebral Near Infrared Spectroscopy Monitoring in Term Infants With Hypoxic Ischemic Encephalopathy-A Systematic Review","volume":"11","author":"Mitra","year":"2020","journal-title":"Front Neurol"},{"key":"2025123106471524000_15.8.e107083.56","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1396692"},{"key":"2025123106471524000_15.8.e107083.57","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.84"},{"key":"2025123106471524000_15.8.e107083.58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41372-020-00910-w","article-title":"Association between cerebral oxygen saturation and brain injury in neonates receiving therapeutic hypothermia for neonatal encephalopathy","volume":"41","author":"Szakmar","year":"2021","journal-title":"J Perinatol"},{"key":"2025123106471524000_15.8.e107083.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2017.07.008"},{"key":"2025123106471524000_15.8.e107083.60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clp.2024.04.005","article-title":"Advances in Neuroimaging Biomarkers and Scoring","volume":"51","author":"Machie","year":"2024","journal-title":"Clin Perinatol"},{"key":"2025123106471524000_15.8.e107083.61","doi-asserted-by":"crossref","unstructured":"Chakkarapani E , de Vries LS , Ferriero DM , et al . Neonatal encephalopathy and hypoxic-ischemic encephalopathy: the state of the art. Pediatr Res 2025. doi:10.1038\/s41390-025-03986-2","DOI":"10.1038\/s41390-025-03986-2"},{"key":"2025123106471524000_15.8.e107083.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.09.043"},{"key":"2025123106471524000_15.8.e107083.63","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70295-9"},{"key":"2025123106471524000_15.8.e107083.64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ebiom.2019.08.034","article-title":"Prospective qualification of early cerebral biomarkers in a randomised trial of treatment with xenon combined with moderate hypothermia after birth asphyxia","volume":"47","author":"Azzopardi","year":"2019","journal-title":"EBioMedicine"},{"key":"2025123106471524000_15.8.e107083.65","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24758"},{"key":"2025123106471524000_15.8.e107083.66","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00235","article-title":"Peak Width of Skeletonized Water Diffusion MRI in the Neonatal Brain","volume":"11","author":"Blesa","year":"2020","journal-title":"Front Neurol"},{"key":"2025123106471524000_15.8.e107083.67","doi-asserted-by":"crossref","DOI":"10.1016\/j.dcn.2024.101488","article-title":"Harmonizing multisite neonatal diffusion-weighted brain MRI data for developmental neuroscience","volume":"71","author":"Bonthrone","year":"2025","journal-title":"Dev Cogn Neurosci"},{"key":"2025123106471524000_15.8.e107083.68","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00362-016-0790-7","article-title":"Incoherent dose-escalation in phase I trials using the escalation with overdose control approach","volume":"PMCID","author":"Wheeler","year":"2018","journal-title":"Stat Pap (Berl"},{"key":"2025123106471524000_15.8.e107083.69","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-086394","article-title":"Recombinant fragment of human surfactant protein D to prevent neonatal chronic lung disease (RESPONSE): a protocol for a phase I safety trial in a tertiary neonatal unit","volume":"14","author":"Bhatt","year":"2024","journal-title":"BMJ Open"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-107083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:49:15Z","timestamp":1767192555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-107083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,22]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjopen-2025-107083"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-107083","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}